What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials

BACKGROUND: Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) has increased in incidence in recent decades. With higher cure rates in younger populations, long-term survivors may live with acute- and long-term toxicity, leading to increased interest in de-escalation...

Descripción completa

Detalles Bibliográficos
Autores principales: Mensour, Emma A., Alam, Shintha, Mawani, Seliya, Bahig, Houda, Lang, Pencilla, Nichols, Anthony, Palma, David A., Jasper, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816564/
https://www.ncbi.nlm.nih.gov/pubmed/36620554
http://dx.doi.org/10.3389/fonc.2022.1067321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816564/
https://www.ncbi.nlm.nih.gov/pubmed/36620554
http://dx.doi.org/10.3389/fonc.2022.1067321

Ejemplares similares